Day, C.; Silva, J.-P.; Munro, R.; Mullier, B.; André, V.M.; Wolff, C.; Stephens, G.J.; Bithell, A.
Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity. Pharmaceuticals 2024, 17, 1643.
https://doi.org/10.3390/ph17121643
AMA Style
Day C, Silva J-P, Munro R, Mullier B, André VM, Wolff C, Stephens GJ, Bithell A.
Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity. Pharmaceuticals. 2024; 17(12):1643.
https://doi.org/10.3390/ph17121643
Chicago/Turabian Style
Day, Charlotte, John-Paul Silva, Rebecca Munro, Brice Mullier, Véronique Marie André, Christian Wolff, Gary J. Stephens, and Angela Bithell.
2024. "Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity" Pharmaceuticals 17, no. 12: 1643.
https://doi.org/10.3390/ph17121643
APA Style
Day, C., Silva, J.-P., Munro, R., Mullier, B., André, V. M., Wolff, C., Stephens, G. J., & Bithell, A.
(2024). Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity. Pharmaceuticals, 17(12), 1643.
https://doi.org/10.3390/ph17121643
